This document discusses drugs used to treat respiratory system disorders like asthma and COPD. It focuses on bronchodilators, including beta-agonists like albuterol, which work by stimulating beta-2 receptors to dilate airways. Xanthine derivatives and anticholinergics are also discussed as bronchodilator drug classes. The key points covered include indications for bronchodilator use, mechanisms of action, adverse effects to monitor for, and nursing implications when administering these respiratory drugs.
This document discusses drugs used to treat respiratory system disorders like asthma and COPD. It focuses on bronchodilators, including beta-agonists like albuterol, which work by stimulating beta-2 receptors to dilate airways. Xanthine derivatives and anticholinergics are also discussed as bronchodilator drug classes. The key points covered include indications for bronchodilator use, mechanisms of action, adverse effects to monitor for, and nursing implications when administering these respiratory drugs.
This document discusses drugs used to treat respiratory system disorders like asthma and COPD. It focuses on bronchodilators, including beta-agonists like albuterol, which work by stimulating beta-2 receptors to dilate airways. Xanthine derivatives and anticholinergics are also discussed as bronchodilator drug classes. The key points covered include indications for bronchodilator use, mechanisms of action, adverse effects to monitor for, and nursing implications when administering these respiratory drugs.
This document discusses drugs used to treat respiratory system disorders like asthma and COPD. It focuses on bronchodilators, including beta-agonists like albuterol, which work by stimulating beta-2 receptors to dilate airways. Xanthine derivatives and anticholinergics are also discussed as bronchodilator drug classes. The key points covered include indications for bronchodilator use, mechanisms of action, adverse effects to monitor for, and nursing implications when administering these respiratory drugs.
Download as DOCX, PDF, TXT or read online from Scribd
Download as docx, pdf, or txt
You are on page 1of 5
Kimberly Rose Barawid – Difficulty exhaling – pursed lip
BSN 2-D breathing
– “Pink Puffer” Drugs Affecting the Respiratory System Respiratory System Drugs Bronchodilators and Other Respiratory Drugs COPD Drugs Respiratory System Drugs • Long-term control Lower Respiratory Tract Diseases – Antileukotrienes • Asthma – cromolyn • Emphysema – Inhaled steroids • Chronic bronchitis – Long-acting β2-agonists – Quick relief Respiratory System Drugs – Intravenous systemic corticosteroids Asthma – Short-acting inhaled β2-agonists • Recurrent and reversible shortness of breath • Bronchodilators • Airways become narrow as a result of: – β-adrenergic agonists – Bronchospasm – Xanthine derivatives – Inflammation & Edema of the – Anticholinergics bronchial mucosa • Antileukotrienes – Production of viscid mucus • Corticosteroids • Alveolar ducts/alveoli remain open, but airflow to them is obstructed Respiratory System Drugs • Symptoms Bronchodilators: β-Agonists – Wheezing • Large group, sympathomimetics – Difficulty breathing • Used during acute phase of asthmatic attacks Respiratory System Drugs • Quickly reduce airway constriction Asthma • Stimulate β2-adrenergic receptors • Status asthmaticus throughout the lungs – Prolonged asthma attack that does not respond to typical drug therapy Respiratory System Drugs – May last several minutes to hours Bronchodilators: β-Agonists – Medical emergency Three types Respiratory System Drugs Nonselective adrenergics Chronic Bronchitis – Stimulate α, β1 (cardiac), and β2 • Continuous inflammation of the bronchi (respiratory) receptors and bronchioles – Example: epinephrine • Often occurs as a result of prolonged Nonselective β-adrenergics exposure to bronchial irritants – Stimulate both β1 and β2 receptors • Characterized by – Example: metaproterenol – Hypoxemia – Selective β2 drugs – Chronic productive cough – Stimulate only β2 receptors – “Blue Bloater” – Example: albuterol (Proventil)
Respiratory System Drugs Respiratory System Drugs
Emphysema Bronchodilators: β-Agonists Air spaces enlarge as a result of the Mechanism of Action destruction of alveolar walls • Begins at the specific receptor The surface area where gas exchange takes stimulated# place is reduced • Ends with the dilation of the airways Effective respiration is impaired – #Activation of β2 receptors activates Characterized by: cAMP,* which relaxes smooth – Increased paCO2 - respiratory muscles of the airway and results in acidosis bronchial dilation and increased – Sputum production airflow – Allergies *cAMP = cyclic adenosine – History of respiratory problems monophosphate – Other medications Respiratory System Drugs Respiratory System Drugs Bronchodilators: β-Agonists β-Agonists - Nursing Implications Indications • Monitor for therapeutic effects • Relief of bronchospasm related to asthma, – Decreased dyspnea bronchitis, and other pulmonary diseases – Decreased wheezing, restlessness, • Useful in treatment of acute attacks as well and anxiety as prevention – Improved respiratory patterns with • Used in hypotension and shock return to normal rate and quality • Used to produce uterine relaxation to – Improved activity tolerance prevent premature labor – Patients should know how to use • Hyperkalemia—stimulates potassium to inhalers and MDIs shift into the cell – Have patients demonstrate use of devices Respiratory System Drugs • Monitor for adverse effects β-Agonists: Adverse Effects α-β (epinephrine) Respiratory System Drugs • Insomnia β-Agonists - Patient Education • Restlessness • Patients should be encouraged to have a • Anorexia good state of health • Vascular headache – Avoid exposure to conditions that • Hyperglycemia precipitate bronchospasms • Tremor (allergens, smoking, stress, air • Cardiac stimulation pollutants) – Adequate fluid intake Respiratory System Drugs – Compliance with medical β-Agonists: Adverse Effects treatment β1 and β2 (metaproterenol) – Avoid excessive fatigue, heat, • Cardiac stimulation extremes in temperature, caffeine • Tremor – Patients to get prompt treatment • Anginal pain for flu or other illnesses • Vascular headache • Patients to get vaccinated against • Hypotension pneumonia and flu • Check with their physician before taking any Respiratory System Drugs medication, including OTCs β-Agonists: Adverse Effects • Teach patients to take bronchodilators β2 (albuterol) exactly as prescribed • Hypotension OR hypertension • Vascular headache Respiratory System Drugs • Tremor β-Agonist Derivatives Nsg Implications Respiratory System Drugs • Albuterol, if used too frequently, loses its β-Agonists Nursing Implications β2-specific actions at larger doses • Thorough assessment before beginning – As a result, β1 receptors are therapy stimulated, causing nausea, increased – Skin color anxiety, palpitations, tremors, and – Baseline vital signs increased heart rate – Respirations (should be between • Take medications exactly as prescribed 12 and 24 breaths/min) – No omissions or double doses – Respiratory assessment, including PO2 • Report insomnia, jitteriness, restlessness, – caffeine, theobromine, and palpitations, chest pain, or any change in theophylline symptoms – Only theophylline is used as a Inhalers: bronchodilator Patient Education • Synthetic xanthines: • For any inhaler prescribed, ensure that the (IV) theophylline (Aminophylline) patient is able to self-administer the (oral) theophylline (Elixophyllin, Theo-Dur) medication – Provide demonstration and return Respiratory System Drugs demonstration Bronchodilators – Ensure the patient knows the correct Xanthine Derivatives time intervals for inhalers • Increase levels of energy-producing – Provide a spacer if the patient has cAMP difficulty coordinating breathing – This is done competitively inhibiting with inhaler activation phosphodiesterase (PDE), the – Ensure that patient knows how to enzyme that breaks down cAMP keep track of the number of doses (cAMP = cyclic adenosine in the inhaler device monophosphate) • Result: – decreased cAMP levels, smooth Respiratory System Drugs muscle relaxation, Anticholinergics bronchodilation, and increased Mechanism of Action airflow • Acetylcholine (ACh) causes bronchial – cardiovascular stimulation: constriction and narrowing of the airways increased force of contraction and • Anticholinergics bind to the ACh receptors, increased heart rate, resulting in preventing ACh from binding increased cardiac output and • Result: increased blood flow to the kidneys – bronchoconstriction is prevented (diuretic effect) – airways dilate • ipratropium bromide (Atrovent) and Respiratory System Drugs tiotropium (Spiriva) Bronchodilators • Slow and prolonged action Xanthine Derivatives • Used to prevent bronchoconstriction • Dilate of airways in asthma, chronic • NOT used for acute asthma bronchitis, and emphysema exacerbations! • Mild to moderate cases of acute asthma • Adjunct drug in the management of COPD Respiratory System Drugs • Not used as frequently due to: Anticholinergics – potential for drug interactions Adverse effects – variables related to drug levels in • Dry mouth or throat the blood • Nasal congestion Xanthine Derivatives: • Heart palpitations Adverse Effects • Gastrointestinal distress • Nausea, vomiting, anorexia • Headache • Gastroesophageal reflux during sleep • Coughing • Sinus tachycardia, extrasystoles, • Anxiety palpitations, ventricular dysrhythmias • Transient increased urination No known drug interactions Xanthine Derivatives Respiratory System Drugs Nursing Implications Bronchodilators • Contraindications: history of PUD or GI Xanthine Derivatives disorders • Plant alkaloids: • Cautious use: cardiac disease • Timed-release preparations should not be • Decrease neutrophil and leukocyte crushed or chewed (causes gastric infiltration to the lungs, preventing irritation) inflammation • Report to physician: – Palpitations Nausea Vomiting Respiratory System Drugs – Weakness Dizziness Chest Antileukotrienes – Indications pain • Prophylaxis and chronic treatment of – Convulsions asthma in adults and children older than • Interactions with cimetidine, oral age 12 contraceptives, allopurinol, certain • NOT meant for management of acute antibiotics elevate serum xanthine blood asthmatic attacks levels • montelukast (Singulair) • Nicotine & caffeine potentiate cardiac – is approved for use in children effects ages 2 and older, and for treatment • St. John’s wort increases metabolism = of allergic rhinitis decrease blood levels Respiratory System Drugs Respiratory System Drugs Antileukotrienes: Adverse Effects Antileukotrienes zileuton (Zyflo) zafirlukast (Accolate) • Also called Headache Headache leukotriene receptor antagonists (LRTAs) Dyspepsia Nausea • Newer class of asthma drugs Nausea Diarrhea Currently available drugs Dizziness Liver dysfunction • montelukast (Singulair) Insomnia • zafirlukast (Accolate) Liver dysfunction • zileuton (Zyflo) Respiratory System Drugs Montelukast (Singulair) has fewer adverse Antileukotrienes effects • Leukotrienes – substances released when a trigger, Respiratory System Drugs such as cat hair or dust, starts a series Nursing Implications – Pt Ed of chemical reactions in the body • Ensure that the drug is being used for – cause inflammation, chronic management of asthma, not acute bronchoconstriction, and mucus asthma production • Teach the patient the purpose of the – Result: coughing, wheezing, therapy shortness of breath • Improvement should be seen in about 1 week Respiratory System Drugs • Check with physician before taking any Mechanism of Action OTC or prescribed medications—many • Antileukotriene drugs drug interactions – prevent leukotrienes from attaching • Assess liver function before beginning to receptors on cells in and in therapy circulation • Medications should be taken every night • Inflammation in the lungs is blocked on a continuous schedule, even if • Asthma symptoms are relieved symptoms improve By blocking leukotrienes: • Prevent smooth muscle contraction of the Respiratory System Drugs bronchial airways Corticosteroids • Decrease mucus secretion • Anti-inflammatory!!! • Prevent vascular permeability • Uses - chronic asthma/COPD exacerbations • Do not relieve acute asthmatic attacks S&S • Oral, IV (quick acting), or inhaled forms Corticosteroids • Inhaled forms reduce systemic effects Nursing Implications – Pt Education – May take several weeks before full • Teach patients effects are seen – to monitor disease with a peak flow Respiratory System Drugs meter Corticosteroids – use of a spacer device to ensure Mechanism of Action successful inhalations • Stabilize membranes of cells that release – keep inhalers and nebulizer harmful bronchoconstricting substances equipment clean after uses • Also increase responsiveness of bronchial – Tapering doses of oral smooth muscle to β-adrenergic corticosteroids stimulation
Corticosteroids – Indications • Treatment of bronchospastic disorders that are not controlled by conventional bronchodilators • NOT considered first-line drugs for management of acute asthmatic attacks or status asthmaticus
Respiratory System Drugs
Corticosteroids - Adverse Effects • Pharyngeal irritation • Coughing • Dry mouth • Oral fungal infections • Systemic effects are rare because of the low doses used for inhalation therapy Corticosteroids Nursing Implications – Pt Education • Contraindicated in patients with psychosis, fungal infections, AIDS, TB • Teach patients to gargle and rinse the mouth with lukewarm water afterward to prevent the development of oral fungal infections • If a β-agonist bronchodilator and corticosteroid inhaler are both ordered, the bronchodilator should be used several minutes before the corticosteroid to provide bronchodilation before administration of the corticosteroid